Literature DB >> 11334394

Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia.

M Arakawa1, Y Kakuto, K Ichikawa, J Chiba, N Tabata, Y Sasaki.   

Abstract

A 43-year-old man developed fever, skin rash, eosinophillia, and severe renal and liver dysfunction following treatment with allopurinol. The patient died after 3 months of hospitalization. Autopsy revealed systemic cytomegalovirus infection and bacteremia.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11334394     DOI： 10.2169/internalmedicine.40.331

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


  5 in total

1.  Comment on: Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms.

Authors:  Sora Yasri; Viroj Wiwanitkit
Journal:  Singapore Med J       Date:  2018-05       Impact factor: 1.858

2.  Isolated ileal perforation due to cytomegalovirus reactivation during management of terbinafine hypersensitivity.

Authors:  Soichi Sano; Hiroki Ueno; Keiko Yamagami; Yosuke Yakushiji; Yoshihiro Isaka; Isao Kawasaki; Masashi Takemura; Takeshi Inoue; Masayuki Hosoi
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

3.  Viruses may trigger allopurinol hypersensitivity syndrome.

Authors:  Masami Koike; Yoshihiko Kanno; Koji Tomori; Hirokazu Okada; Hiromichi Suzuki
Journal:  NDT Plus       Date:  2008-08

4.  Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature.

Authors:  Abhishek De; Murlidhar Rajagopalan; Aarti Sarda; Sudip Das; Projna Biswas
Journal:  Indian J Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.494

Review 5.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.